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Abstract
BACKGROUND
Obesity rates have increased sharply in recent decades. As there is a growing
number of cases in which acute pancreatitis (AP) is accompanied by obesity, we
found it clinically relevant to investigate how body-mass index (BMI) affects the
outcome of the disease.
AIM
To quantify the association between subgroups of BMI and the severity and
mortality of AP.
METHODS
A meta-analysis was performed using the Preferred Reporting Items for
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Systematic Review and Meta-Analysis (PRISMA) Protocols. Three databases
(PubMed, EMBASE and the Cochrane Library) were searched for articles
containing data on BMI, disease severity and mortality rate for AP. English-
language studies from inception to 19 June 2017 were checked against our
predetermined eligibility criteria. The included articles reported all AP cases with
no restriction on the etiology of the disease. Only studies that classified AP cases
according to the Atlanta Criteria were involved in the severity analyses. Odds
ratios (OR) and mean differences (MD) were pooled using the random effects
model with the DerSimonian-Laird estimation and displayed on forest plots. The
meta-analysis was registered in PROSPERO under number CRD42017077890.
RESULTS
A total of 19 articles were included in our meta-analysis containing data on 9997
patients. As regards severity, a subgroup analysis showed a direct association
between AP severity and BMI. BMI < 18.5 had no significant effect on severity;
however, BMI > 25 had an almost three-fold increased risk for severe AP in
comparison to normal BMI (OR = 2.87, 95%CI: 1.90-4.35, P < 0 .001). Importantly,
the mean BMI of patients with severe AP is higher than that of the non-severe
group (MD = 1.79, 95%CI: 0.89-2.70, P < 0.001). As regards mortality, death rates
among AP patients are the highest in the underweight and obese subgroups. A
BMI < 18.5 carries an almost two-fold increase in risk of mortality compared to
normal BMI (OR = 1.82, 95%CI: 1.32-2.50, P < 0.001). However, the chance of
mortality is almost equal in the normal BMI and BMI 25-30 subgroups. A BMI >
30 results in a three times higher risk of mortality in comparison to a BMI < 30
(OR = 2.89, 95%CI: 1.10-7.36, P = 0.026).
CONCLUSION
Our findings confirm that a BMI above 25 increases the risk of severe AP, while a
BMI > 30 raises the risk of mortality. A BMI < 18.5 carries an almost two times
higher risk of mortality in AP.
Key words: Acute pancreatitis; Body-mass index; Obesity; Severity; Mortality;
Prognostic; Meta-analysis
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: It is the first detailed analysis on all World Health Organization body-mass
index (BMI) categories, by comparing the normal BMI subgroup to all other subgroups
of BMI with regard to both severity and mortality in acute pancreatitis (AP). Here we
show that a BMI above 25 increases the risk of severe AP, while a BMI > 30 raises the
risk of mortality. A BMI lower than eighteen point five carries an almost two times
higher risk of mortality in AP.
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INTRODUCTON
Obesity is one of the dominant public health concerns worldwide. It is a major risk
factor for various diseases such as diabetes, cardiovascular disease, some cancers,
kidney  disease,  obstructive  sleep  apnea,  gout,  osteoarthritis,  and  hepatobiliary
disease[1]. The increasing prevalence of obesity (Figures 1 and 2)[2] also places a huge
financial burden on national healthcare systems: according to a review published in
2010,  obesity  alone  accounts  for  between  0.7%  and  2.8%  of  total  healthcare
expenditures, while costs associated with a body-mass index (BMI) ≥ 25 reach as high
as 9.1% of total spending on medical care[3].
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Figure 1
Figure 1  The rate of individuals with a body-mass index ≥ 25 among adults in 1976. Source: Global Health Observatory data repository
http://apps.who.int/gho/data/node.main.A897A?lang=en.
The most common method for measuring obesity is BMI, which is calculated from a
person’s weight in kilograms and height in meters (kg/m2). BMI is divided into five
categories  according  to  the  World  Health  Organization  (WHO)  classification:
underweight (< 18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25-29.9
kg/m2), obese class I (30-34.9 kg/m2), obese class II (35-39.9 kg/m2) and obese class III
(≥ 40 kg/m2)[4].
Among various other diseases, there is an increasing number of clinical cases in
which acute pancreatitis (AP) is also accompanied by high BMI. Characterized by
high mortality,  AP is the most frequent cause of acute hospitalization among all
gastrointestinal disorders with a prevalence of 10-100/100000 cases worldwide [5]. The
B5 point of the IAP/APA evidence-based guidelines highlights the importance of
predicting the primary endpoints of AP, namely severity and mortality, therefore, we
found it crucially important to investigate how obesity affects the outcome of the
disease[6]. Numerous studies have also linked severe acute pancreatitis (SAP) with
obesity. The majority of the clinical trials conducted with the aim of determining the
sensitivity and specificity of the predictive score systems of AP with the obesity factor
added to it resulted in greater diagnostic accuracy[7-9].
Despite the fact that there is evidence of high BMI exacerbating AP, there has been
a lack of structured and completed analyses. Until now, four meta-analyses have been
performed to investigate the prognostic role of BMI in AP; however, none of them (1)
analyzed all five WHO BMI categories, (2) compared the normal BMI group to every
other subgroup, (3) investigated the effect of underweight on AP outcome or (4)
suggested cut-off values[10-13]. The last meta-analysis on this topic was conducted in
2011, so our update involves new articles published during the last six years, leading
to a remarkably higher patient number than before.
MATERIALS AND METHODS
Literature search
This meta-analysis was conducted following the guidelines proposed by the PRISMA
Statement [14].  The  protocol  was  previously  registered  on  PROSPERO  under
CRD42017077890. A systematic search of the medical literature was performed using
PubMed, EMBASE and the Cochrane Library.  In all  the databases,  the following
keywords were used for the search: acute pancreatitis AND BMI AND (severity OR
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Figure 2
Figure 2  The rate of individuals with a body-mass index ≥ 25 among adults 40 years later in 2016. Source: Global Health Observatory data repository
(http://apps.who.int/gho/data/node.main.A897A?lang=en).
mortality). Results were imported into reference manager software (EndNote X7.5).
The reference lists in the articles were also checked to capture all relevant articles
published within our topic of interest. The last literature search in the same databases
was completed on 22nd December 2017. The details of these literature searches are
included in the Supporting Material. We adapted the PICO format to set the inclusion
criteria. Our PICO items were the following: (P) patients with AP, (I) low/high BMI,
(C) normal BMI, and (O) severity and mortality of pancreatitis. Besides these two
major endpoints of AP, we also collected data on the length of hospitalization and
local or systemic complications for the purpose of analysis.
Study selection
Two of the authors independently checked whole texts with figures and tables against
our predetermined eligibility criteria. During the selection process, meta-analyses,
reviews, case reports and abstracts with inadequate data were excluded. Articles were
declared eligible  if  the study enrolled all  AP patients  with no restriction on one
specific  etiology.  In the severity analysis,  we only included studies in which the
original[15] or the revised[16] version of the Atlanta Criteria were used to determine the
severity of AP. However, in the analysis of the effect of BMI on mortality, the use of
the Atlanta Classification was not a criterion.
Data extraction
Review authors entered the following main data from the eligible articles (Table 1) on
an Excel sheet: (1) First author, year of publication, country; (2) Study type; (3) Group
of enrolled patients; (4) BMI subgroups and sample sizes; (5) Method used to define
disease severity; (6) Mean BMI; (7) Number of severe cases and mortality; (8) Mean
length of hospitalization and mean Intensive Care Unit stay in days; (9) Mean or
median severity scores: Acute Physiology and Chronic Health Disease Classification
System II (APACHE II) and Ranson’s score; and (10) Number of cases with necrosis
development. Discrepancies were resolved by consensus.
Risk of bias
Risk  of  bias  assessment  was  carried  out  according  to  a  modified  version  of  the
Newcastle-Ottawa Scale (NOS) to rate the internal validity of the individual studies,
and funnel plots were constructed to assess the risk of publication bias (Supporting
Material).
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Table 1  Characteristics of the included studies
Ref. Country Type of study Total no. of patients Groups BMI groups Sample size
Bota et al[32] Romania Retrospective 334 Mild 207
Severe 127
Duarte-Rojo et al[18] Mexico Prospective 99 Mild 74
Severe 25
Funnel et al[29] South Africa Prospective 99 < 19 15
19-25 48
26-29 17
≥ 30 19
Karpavicius et al[23] Lithuania Prospective 102 Mild and moderate 82
Severe 20
Katuchova et al[21] Slovakia Prospective 384 IEP 293
SAP 91
Mery et al[25] Mexico Prospective 88 < 25 34
25-29.9 32
≥ 30 22
Papachristou et al[8] United States Prospective 102 < 30 74
≥ 30 28
Párniczky et al[5] Hungary Prospective, multicenter 446 < 18.5 26
18.5-24.9 136
25-29.9 154
30-34.9 86
35-39.9 24
> 40 20
Sharma et al[30] United States Prospective 128 < 30 87
≥ 30 41
Shin et al[20] South Korea Retrospective 374 18.5-22.9 170
23-24.9 96
25-29.9 97
≥ 30 11
Suazo-Barahona et al[26] Mexico Retrospective 150 < 25 65
≥ 25 85
Taguchi et al[31] Japan Retrospective 6002 < 18.5 839
18.5-24.9 3767
25-29.9 1106
30-34.9 220
> 35 70
Thandassery et al[27] India Prospective 280 18.5-22.9 131
23-24.9 83
>25 66
Tsai et al[34] Taiwan Prospective 320 < 30 294
≥ 30 26
Türkoglu et al[24] Turkey Prospective cohort study 92 Mild 62
Severe 30
Yang et al[28] China Prospective, multicenter 161 ≥ 25 82
≥ 25 79
Yashima et al[22] Japan Prospective 124 Mild 76
Severe 48
Yeung et al[19] China Prospective 101 < 25 19
≥ 25 82
Yoon et al[17] South Korea Retrospective 203 Mild 128
Moderate 62
Severe 13
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BMI: Body-mass index; IEP: Interstitial edematous pancreatitis; SAP: Severe acute pancreatitis.
Statistical analysis
The statistical analysis was conducted with Stata 11 SE (Stata Corp, College Station,
TX, United States). First, we calculated mean differences from BMI in severe and non-
severe groups and odds ratios (OR) for severity and mortality outcomes based on
patient numbers in different BMI categories. ORs and mean differences were pooled
using the random effects model with the DerSimonian-Laird estimator and displayed
on forest  plots.  Summary OR and mean estimation,  P-value and 95% confidence
interval (CI) were calculated. P < 0.05 was considered a significant difference from
summary OR = 1 or mean = 0. Statistical heterogeneity was analyzed using the I2
statistic and the chi-square test to obtain probability values; P < 0.05 was determined
to indicate significant heterogeneity. We investigated the possible signs of a small
study effect, displaying the studies on a funnel plot with the trim and fill algorithm.
RESULTS
The systematic search of the literature yielded 262 items. After eliminating duplicates,
217 records were screened by title and abstract. 156 articles were included in the full-
text assessment, of which 15 studies met our predetermined eligibility criteria. An
additional four articles included in the quantitative synthesis were found by checking
the references of the originally identified articles (Figure 3).
The interpretation of cut-off values was not unified in the enrolled studies that
investigated the effect of obesity in AP. As articles used different BMI grouping and
not  all  articles  contained data  on all  BMI subgroups,  we decided to  use  several
statistical approaches.
Severity
Nine articles[17-24,32]  presented data on the mean BMI of the non-severe and severe
patient groups (Figure 4). This meta-analysis showed that severe AP patients have a
significantly higher BMI compared to those with moderately severe and severe AP
(MD = 1.79, 95%CI: 0.89-2.70, P < 0.001). AP patients with a BMI > 25 are almost three
times more likely to develop a severe disease than normal weight and underweight
patients (OR = 2.87, 95%CI: 1.90-4.35, P < 0.001) according to the analysis of data from
eight additional studies[5,19-20,25-29] (Figure 5). Data from five articles[5,20,25,29-30] also made it
possible to set a BMI of 30 kg/m2 as a cut-off value in our severity analysis. There is a
sharp difference between obese and non-obese patients in the chance for developing a
severe disease: a patient with a BMI > 30 has an almost four times higher odds of SAP
than one with a BMI < 30 (OR = 3.61, 95%CI: 1.56-8.36, P = 0.003) (Figure 6).
Comparing the normal BMI group to every other BMI category (< 18.5; 25-30; 30-35;
> 35 kg/m²) in a summary effect analysis (Figure 7) showed that overweight and
obese patients are more likely to develop a severe disease than patients in all other
BMI categories (OR = 2.53, 95%CI: 1.64-3.90, P = 0.000 and OR = 2.99, 95%CI: 1.13-7.92,
P = 0.028). Underweight compared to normal BMI also seems to increase the risk of
severe AP (OR = 1.89, 95%CI: 0.52-6.87, P = 0.336); however, the differences are not
significant. The reason behind the lack of significance may be the particularly low
number of patients in the underweight subgroup (n = 184). Forming subgroups from
each BMI category (underweight, normal weight, overweight and obese) confirmed
the previously identified tendency:  the higher the BMI,  the higher the chance of
developing severe AP (Figure 8).
Mortality
A total of ten[5,8,19-20,25-29,31] of the 19 enrolled studies were included in this part of the
meta-analysis. While a BMI > 25 represents a higher chance of developing severe AP,
it does not significantly increase the mortality of the disease (OR = 2.46, 95%CI: 0.78-
7.79, P = 0.125) (Figure 9). However, obese patients are at a three-fold increased risk of
mortality compared to those with a BMI < 30 (OR = 2.89, 95%CI: 1.14-7.36, P = 0.026)
(Figure 10). One with a BMI < 18.5 is also at a significantly higher risk of mortality in
AP than a normal weight patient (OR = 1.82, 95%CI: 1.32-2.50, P = 0.000) (Figure 11).
Death  rates  among  AP  patients  are  the  highest  in  the  underweight  and  obese
subgroups (Figures 12 and 13), while the chance of mortality is almost equal in the
normal BMI and BMI 25-30 subgroups.
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Figure 3
Figure 3  Flowchart of the study selection procedure.
DISCUSSION
The first meta-analysis[10] on the topic of AP and BMI was published by Martínez et al
in 2004, concluding that obesity significantly increases the risk of local or systemic
complications in AP. Since then, three more meta-analyses have also confirmed the
prognostic role of BMI in the disease, leading to even more specific results. The first
meta-analysis was updated two years later by the same author[11], confirming that
obesity not only raises the risk of complications, but also increases the mortality in
AP. In 2011, Wang et al[12] highlighted that overweight (BMI > 25) also increases the
incidence of SAP, while Hong et al[13] drew attention to the prognostic role of body
weight in AP development in their meta-analyses.
The  main  purpose  of  the  present  meta-analysis  was  to  precisely  evaluate  the
predictive value of BMI in AP by assessing what is already known and confirmed by
evidence and to offer guidance on its use in clinical practice.
Severity
Seven of the included articles in this meta-analysis found a clear correlation between
overweight or obesity and the development SAP. Two studies showed no significant
relation between BMI and disease severity in AP[5,32]. Three articles[17-18,22] analyzed the
effect of BMI in comparison with other tools for measuring obesity. These studies
stated that abdominal obesity (waist circumference), peripancreatic visceral adipose
tissue and visceral fat-to-muscle ratio have a stronger correlation with SAP than BMI
or body weight. We were also prepared to do an analysis of these data, but abdominal
obesity  is  measured  differently  in  each  study[18,21-22,25,33],  making  a  meta-analysis
inapplicable. One of the enrolled studies compared the accuracy of different scoring
systems in predicting the severity of AP[19], in which the addition of the obesity factor
did  not  seem  to  improve  the  accuracy  of  the  APACHE  II  scoring  system.  An
interventional  clinical  trial[28]  was  also  conducted  in  this  area,  resulting  in  the
successful  prevention  of  severe  AP  in  obese  patients  with  the  intravenous
administration of octreotide.
Although previous studies have already confirmed the relation between BMI and
the major endpoints of AP, it is still not incorporated into the scoring systems that aim
to predict disease outcome. A prospective study involving 186 consecutive patients
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Figure 4
Figure 4  Forest plot of mean body-mass index in the non-severe and severe patient subgroups. Filled circles
represent the mean difference derived from the studies analyzed. Horizontal bars represent 95%CI. Empty
rhombuses show the overall, combined mean difference (point estimation is the middle of the rhombus and CIs are
the edges). CI: Confidence interval.
published by Johnson et al[7] in 2004 resulted in the improved prediction of severity in
AP  by  adding  the  obesity  factor  to  the  APACHE  II  scoring  system  (Admission
APACHE-O > 9: sensitivity 82%, specificity 86%, PPV 74%, NPV 91% and accuracy
85%; admission APACHE II > 9: sensitivity 68%, specificity 84%, PPV 71%, NPV 81%
and accuracy 80%). Prevalence of complications increased among patients with a BMI
26-30 (score = 1), while mortality rates were significantly higher among BMI > 30
(score = 2) patients. Two years later, a prospective study of 101 patients[8] also stated
that obesity is an independent risk factor for severe AP and that the APACHE-O
scoring  system is  not  significantly  better,  but  it  has  a  similar  predictive  ability
compared to APACHE II (Admission APACHE-O > 9: sensitivity 84%, specificity
82%, PPV 52%, NPV 96% and accuracy 83%; admission APACHE II > 9: sensitivity
74%, specificity 85%, PPV 47%, NPV 93% and accuracy 80%). In 2012, a cross-sectional
retrospective study by Guzman et al[9] added the BMI parameter to the Bedside Index
of  Severity  in  Acute  Pancreatitis  (BISAP)  score  and  achieved  higher  diagnostic
accuracy than the original scoring system (sensitivity 75%, specificity 96.4%, PPV 80%,
NPV 95.2% and accuracy 92.3%).
Mortality
All the included articles found a correlation between BMI and mortality in AP. One
study[31] identified underweight as another independent risk factor for a fatal disease
outcome, and our meta-analysis confirmed this. However, the number of patients was
very low in this subgroup.
Limitations
Overweight  and  obesity  are  often  accompanied  by  other  chronic  diseases  and
metabolic derangements such as hypertension, diabetes and hypertriglyceridemia. As
we did not take demographic factors and comorbidities into consideration, we cannot
conclude if BMI is an independent or associated risk factor in AP, which is a limitation
of this study.
Strengths
Our meta-analysis is much more comprehensive and detailed compared to the earlier
ones. This work performs the first detailed analysis on all WHO BMI categories, by
comparing the normal BMI subgroup to all other subgroups of BMI with regard to
both severity and mortality in AP. Our subgroup analysis also investigated each BMI
category, this way, we are now able to determine which BMI groups are most in
danger of a severe or even fatal outcome in AP.
In conclusion, the findings of this meta-analysis demonstrated that a BMI above 25
increases the risk of severe AP, but not mortality, while a BMI > 30 raises the risk of
both severity and mortality in AP. A BMI < 18.5 carries an almost two times higher
risk of mortality in AP.
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Figure 5
Figure 5  Forest plot of severe acute pancreatitis in the body-mass index < 25 and body-mass index > 25 subgroups. Filled circles represent the odds ratio
derived from the studies analyzed. Horizontal bars represent 95%CI. Empty rhombuses show the overall, combined effect (OR is the middle of the rhombus and CIs
are the edges). BMI: Body-mass index; CI: Confidence interval; OR: Odds ratio.
Figure 6
Figure 6  Forest plot of severe acute pancreatitis in the body-mass index < 30 and body-mass index > 30 subgroups. Filled circles represent the odds ratio
derived from the studies analyzed. Horizontal bars represent 95%CI. Empty rhombuses show the overall, combined effect (OR is the middle of the rhombus and CIs
are the edges). BMI: Body-mass index; CI: Confidence interval; OR: Odds ratio.
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Figure 7
Figure 7  Forest plot of acute pancreatitis severity comparing the normal body-mass index group (body-mass index 18.5-25) to other body-mass index
categories. Filled circles represent the odds ratio derived from the studies analyzed. Horizontal bars represent 95% CI. Empty rhombuses show the overall, combined
effect (OR is the middle of the rhombus and CIs are the edges). BMI: Body-mass index; CI: Confidence interval; OR: Odds ratio.
Figure 8
Figure 8  Subgroup analysis of body-mass index and acute pancreatitis severity displayed on forest plot. Filled circles represent the odds ratio derived from
the studies analyzed. Horizontal bars represent 95%CI. Empty rhombuses show the overall, combined effect (OR is the middle of the rhombus and CIs are the edges).
CI: Confidence interval.
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Figure 9
Figure 9  Forest plot of mortality comparing the body-mass index < 25 and body-mass index > 25 subgroups. Filled circles represent the odds ratio derived
from the studies analyzed. Horizontal bars represent 95% CI. Empty rhombuses show the overall, combined effect (OR is the middle of the rhombus and CIs are the
edges). BMI: Body-mass index; CI: Confidence interval; OR: Odds ratio.
Figure 10
Figure 10  Forest plot of mortality comparing the body-mass index < 30 and body-mass index > 30 subgroups. Filled circles represent the odds ratio derived
from the studies analyzed. Horizontal bars represent 95%CI. Empty rhombuses show the overall, combined effect (OR is the middle of the rhombus and CIs are the
edges). BMI: Body-mass index; CI: Confidence interval; OR: Odds ratio.
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Figure 11
Figure 11  Forest plot of mortality comparing the normal body-mass index group (body-mass index 18.5-25) to other body-mass index categories. Filled
circles represent the odds ratio derived from the studies analyzed. Horizontal bars represent 95% CI. Empty rhombuses show the overall, combined effect (OR is the
middle of the rhombus and CIs are the edges). BMI: Body-mass index; CI: Confidence interval; OR: Odds ratio.
Figure 12
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Figure 12  Subgroup analysis of body-mass index and acute pancreatitis mortality displayed on forest plot. Filled circles represent the odds ratio derived from
the studies analyzed. Horizontal bars represent 95%CI. Empty rhombuses show the overall, combined effect (OR is the middle of the rhombus and CIs are the edges).
CI: Confidence interval.
Figure 13
Figure 13  Model for the effect of body-mass index on severity (A) and mortality (B).
ARTICLE HIGHLIGHTS
Research background
The worldwide incidence of obesity is increasing and previous studies stated that it worsens the
outcome of AP.
Research motivation
We wanted to provide detailed guidance on the clinical use of BMI in prognostic scoring.
Research objectives
To exactly identify which BMI subgroups are most in danger of a severe or even fatal disease
outcome in AP.
Research methods
A systematic search was carried out in PubMed, Embase and Cochrane Library databases for
studies investigating the effect of BMI on the outcome of AP. We used the PRISMA protocol,
registered our project in PROSPERO and assessed the quality of the included articles by using a
modified version of the Newcastle-Ottawa Scale. The statistical calculations were performed
with Stata 11 SE, using the random effects model (DerSimonian-Laird method).
Research results
9997 patients with acute pancreatitis were included (19 articles) in this analysis. We found that
AP patients with a BMI > 25 have a significantly increased risk of SAP with an OR of 2.87. A BMI
> 30 means a significantly increased risk of mortality (OR = 2.89) while one with a BMI < 18.5 is
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also at a significantly higher risk of mortality compared to normal weight patients with an OR of
1.82.
Research conclusions
The new findings of this study identified that a BMI above 25 increases the risk of severe AP, but
not mortality, while a BMI > 30 raises the risk of mortality. A BMI < 18.5 carries an almost two
times higher risk of mortality in AP. It is the first meta-analysis that performs a detailed analysis
on  all  WHO  BMI  categories  with  regard  to  both  primary  endpoints  of  AP.  This  helps  to
determine which BMI groups are at the highest risk of severe or even fatal outcome in AP.
Research perspectives
Our results give the opportunity for researchers to prepare the guidelines and scoring systems
more precisely.
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